Clinical trial
Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred…
NCT00003153 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003153 |
|---|---|
| Title | Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation |
| Official title | Phase II Study of Salvage Cellular Immunotherapy for Patients With Persistent or Recurrent Multiple Myeloma After Allogeneic Bone Marrow Transplantation From an HLA-Matched Sibling Donor |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Biological |
| Interventions | therapeutic allogeneic lymphocytes |
| Enrollment | 22 |
| Start date | Jul 22, 1998 |
| Primary completion | Feb 1, 2007 |
| Completion | May 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 15, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: